Post-kala-azar Dermal leishmaniasis: Facing the challenge of eliminating Kala-Azar from South Asia

Kala Azar in South Asia: Current Status and Challenges Ahead

Volumn , Issue , 2011, Pages 111-124

  Desjeux, Philippe ^a   Ramesh, V ^b  

^a Institute for OneWorld Health   (United States)

^b SAFDARJUNG HOSPITAL   (India)

Author keywords

Bangladesh; India; Kala azar; Nepal; Post kala azar dermal leishmaniasis; Visceral leishmaniasis; Visceral leishmaniasis elimination program

Indexed keywords

EID: 79960636080     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-94-007-0277-6_11     Document Type: Chapter

References (44)

1. Ramesh V, Mukherjee A. Post-kala-azar dermal leishmaniasis. Int J Dermatol 1995;34:85-91.
2. Singh RP. Observation on dermal leishmanoid in Bihar. Ind J Dermatol. 1968;13:59-63.
3. Napier LE, Kirwan E O G, Sen G. Eye complications of dermal leishmanoid. Ind Med Gaz. 1941;76:542-5.
4. Ramesh V, Ramam M, Singh R, Salotra P. Hypopigmented post-kala-azar dermal leishmaniasis. Int J Dermatol. 2008;47:414-6.
5. Ramesh V, Singh N. A clinical and histopathological study of macular type of post-kala-azar dermal leishmaniasis. Trop Doct. 1999;29:205-7.
6. Saha S, Mazumdar T, Anam K, et al. Leishmania promatigote membrane antigen-based enzyme-linked immunosorbent assay and immunoblotting for differential diagnosis of Indian post-kala-azar dermal leishmaniasis. J Clin Microbiol. 2005;43:1269-7.
7. Musa AM, Khalil E A G, Raheem MA, et al. The natural history of Sudanese post-kalaazar dermal leishmaniasis: clinical, immunological and prognostic features. Annal Trop Med Parasitol. 2002;96:765-2.
8. Zijlstra EE, Musa AM, Khalil E A G, et al. Post-kala-azar dermal leishmaniasis. Lancet Infect Dis. 2003;3:87-8.
9. Ismail A, Khalil E A G, Musa AM, et al. The pathogenesis of post-kala-azar dermal leishmaniasis from the field to the molecule: Does ultraviolet light (UVB) radiation play a role? Med Hypotheses. 2006;66:993-9.
10. El Hassan AM, Khalil E A G, El Sheikh EA, et al. Post-kala-azar ocular leishmaniasis. Trans Roy Soc Trop Med Hyg. 1998;92:177-9.
11. Antinori S, Longhi E, Bestetti G, et al. Post-kala-azar dermal leishmaniasis as an immune reconstitution inflammatory syndrome in a patient with acquired immune deficiency syndrome. Br J Dermatol. 2007;157:1032-6.
12. Rahman KM, Islam S, Rahman MW, et al. Increasing incidence of post-kala-azar dermal leishmaniasis in a population-based study in Bangladesh. Clin Inf Dis. 2010;50:73-6.
13. Croft SL. PKDL - a drug related phenomenon? Ind J Med Res. 2008;128:10-1.
14. Thakur CP, Kumar A, Mitra G, et al. Impact of amphotericin-B in the treatment of kala-azar on the incidence of PKDL in Bihar, India. Ind J Med Res. 2008;128:38-4.
15. Agarwal A, Sinha A, Rizal A, Rizal S 2006, Post-kala-azar dermal leishmaniasis in eastern Nepal 2006, 13th International Congress on Oral Pathology and Medicine (abstract).
16. Salotra P, Singh R. Challenges in the diagnosis of post-kala-azar dermal leishmaniasis. Ind J Med Res. 2006;123:295-10.
17. Salotra P, Sreenivas G, Ansari NA, Subba Raju BV, Ramesh V. Evaluation of enzyme-linked immunosorbent assay for diagnosis of post-kala-azar dermal leishmaniasis with crude or recombinant rk39 antigen. Clin Diagn Lab Immunol. 2002;9:370-3.
18. Salotra P, Sreenivas G, Pogue GP, et al. Development of a species-specific PCR assay for detection of Leishmania donovani in clinical samples from patients with kala-azar and postkalaazar dermal leishmaniasis. J Clin Microbiol. 2001;39:849-4.
19. Boehme CC, Nabeta P, Henostroza G, et al. Operational feasibility of using loop-mediated isothermal amplification for diagnosis of pulmonary tuberculosis in microscopy centers of developing countries. J Clin Microbiol. 2007;45:1936-40.
20. Takagi H, Itoh M, Zahidul Islam M, et al. Sensitive, specific, and rapid detection of Leishmania donovani DNA by loop-mediated isothermal amplification. Am J Trop Med Hyg. 2009;81:578-2.
21. El-Hassan AM, Ghalib HW, Zijlstraa EE, et al. Post kala azar dermal leishmaniasis in the Sudan: clinical features, pathology and treatment. Trans R Soc Trop Med Hyg. 1992;86:245-8.
22. Ismail A, Kharazmi A, Permin H, et al. Detection and characterization of leishmania in tissues of patients with post kala azar dermal leishmaniasis using a specific monoclonal antibody. Trans R Soc Trop Med Hyg. 1997;91:283-5.
23. Mukherjee A, Ramesh V, Misra RS. Post kala azar dermal leishmaniasis: a light and electron microscopic study of 18 cases. J Cutan Pathol. 1993;20:320-5.
24. Singh N, Ramesh V, Arora VK, et al. Nodular post kala azar dermal leishmaniasis: a distinct histopathological study. J Cutan Pathol. 1998;25:95-9.
25. Beena KR, Ramesh V, Mukherjee A. Identification of parasite antigen, correlation of parasite density and inflammation in skin lesions of post kala azar dermal lesihmaniasis. J Cut Pathol. 2003;30:616-20.
26. Singh A, Ramesh V, Ramam M, Sood N. Histomorphological spectrum of post kala azar dermal leishmaniasis: a study of 52 cases from India (manuscript under preparation)
27. Thakur CP, Narain S, Kumar N, et al. Amphotericin B is superior to sodium antimony gluconate in the treatment of Indian post-kala-azar dermal leishmaniasis. Annals Trop Med Parasitol. 1997;91:611-6.
28. Berman J. Treatment of leishmaniasis with miltefosine: 2008 status. Expert Opin Drug Metab Toxicol. 2008;4:1209-6.
29. Rathi SK, Pandhi RK, Khanna N, Chopra P. Therapeutic trial of sodium antimony gluconate alone and in combination with ketoconazole in post-kala-azar dermal leishmaniasis. Ind J Dermatol Venereol Leprol. 2003;69:392-3.
30. Ramesh V, Kumar J, Kumar D, Salotra P. A retrospective study of intravenous sodium antimony gluconate alone and in cominations with rifampicin, allopurinol and an immunomodulator in the treatment of Indian post-kala-azar dermal leishmaniasis. Ind J Dermatol Venereol Dermatol 2010;76:138-44.
31. Musa AM, Khalil EA, Mahgoug FA, et al. Efficacy of liposomal amphotericin B (Ambisome) in the treatment of persistent post-kala-azar dermal leishmaniasis. Ann Trop Med Parasitol. 2005;99:563-9.
32. Musa AM, Khalil G A E, Mahgoub E A F, et al. Immunochemotherapy of persistent post-kalaazar dermal leishmaniasis: a novel approach to treatment. Trans Roy Soc Trop Med Hyg. 2008;102:58-3.
33. Dey A, Singh S. Genetic heterogeneity among visceral and post-kala-azar dermal leishmaniasis strains from eastern India. Infect Genet Evol. 2007;7:219-2.
34. Subba Raju BV, Singh R, Sreenivas G, et al. Genetic fingerprinting and identification of diferentially expressed genes in isolates of Leishmania donovani from Indian patients of post-kala-azar dermal leishmaniasis. Parasitol. 2008;135:23-2.
35. Das V N R, Pandey K, Verma N, et al. Start report: Development of post-kala-azar dermal leishmaniasis (PKDL) in miltefosine-treated visceral leishmaniasis. Am J Trop Med Hyg. 2009;80:336-8.
36. Kumar D, Ramesh V, Verma S, et al. Post-kala-azar dermal leishmaniasis (PKDL) developing after treatment of visceral leishmaniasis with amphotericin-B and miltefosine. Annals Trop Med Parasitol. 2009;103:1-4.
37. Elshafie AI, Ahlin E, Mathsson L, et al. Circulating immune complexes (IC) and IC-induced levels of GM-CSF are increased in Sudanese patients with acute visceral Leishmania donovani infection undergoing sodium stibogluconate treatment: implication for diseases pathogenesis. J Immunol. 2007;178:5383-9.
38. Saha S, Mondal S, Ravindran R, et al. IL-10 and TGF-beta-mediated susceptibility in kalaazar and post-kala-azar dermal leishmaniasis: the significance of amphotericin B in the control of Leishmania donovani infection in India. J Immunol. 2007;179:5592-3.
39. Addy M, Nandy A. Ten years of kala-azar in west Bengal, Part I. did post-kala-azar dermal leishmaniasis initiate the outbreak in 24-Parganas? role of nodular form to infect sandflies? Bull World Health Organ. 1992;70:341-6.
40. Dye C, Wolpert DM. Earthquakes, influenza and cycles of Indian kala-azar. Trans R Soc Trop Med Hyg. 1988;82:843-50.
41. Sen Gupta PC. Leishmaniasis in India. J Ind Med Assoc. 1968; A 50:34-6.
42. Alan SN, Mukhopadhyay AK. An epidemiological study on post-kala-azar dermal leishmaniasis in parts of Bihar (India). Indian J Parasitol. 1989;13:295-7.
43. Munro DD. du Vivier A, Jopling WH. post-kala-azar dermal leishmaniasis. Br J Dermatol. 1972;87:374-8.
44. Ono H, Ghoreishi M, Yokozeki H, et al. A case of post-kala-azar dermal leishmaniasis. J Dermatol. 1998;25:118-20.